Form D · Other Health Care
Featherglass Health, Inc.
Baltimore, MD · CIK 0002035967
Offering snapshot reported Sep 4, 2026 · SEC filing
- Reported sold
- $25K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 3, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 4, 2026 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Apr 3, 2025 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Sep 4, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-596449
The securities being offered are Simple Agreements for Future Equity (SAFE)
Source: Form D, filed Sep 4, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Benjamin Israel | Director, Executive, Promoter |
| Jim Nista | Executive |
| Matthew Robinson | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
4801 Yellowwood Ave Suite 2 E1
Baltimore, MD, 21209
Baltimore, MD, 21209